
Company valuation, historical trends, and peer comparisons.
According to Vyome Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.18M. This represents a change of -7.55% compared to the average of 5.61M of the last 4 quarters.
The mean historical Enterprise Value of Vyome Holdings, Inc. over the last ten years is 76.34M. The current 5.18M Enterprise Value has changed -93.21% with respect to the historical average. Over the past ten years (40 quarters), HIND's Enterprise Value was at its highest in in the September 2016 quarter at 997.07M. The Enterprise Value was at its lowest in in the September 2025 quarter at -4154863.98.
Average
76.34M
Median
24.15M
Minimum
-3167095.00
Maximum
432.33M
Discovering the peaks and valleys of Vyome Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 471.20%
Maximum Annual Enterprise Value = 432.33M
Minimum Annual Increase = -13750.55%
Minimum Annual Enterprise Value = -3167095.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.48M | -73.77% |
| 2024 | 9.47M | 471.20% |
| 2023 | 1.66M | -78.38% |
| 2022 | 7.67M | -84.45% |
| 2021 | 49.33M | -25.67% |
| 2020 | 66.36M | 70.88% |
| 2019 | 38.84M | -75.48% |
| 2018 | 158.39M | -63.36% |
| 2017 | 432.33M | -13750.55% |
| 2016 | -3167095.00 | -100.32% |
The current Enterprise Value of Vyome Holdings, Inc. (HIND) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.54M
5-year avg
14.12M
10-year avg
76.34M
Vyome Holdings, Inc.’s Enterprise Value is less than C4 Therapeutics, Inc. (381.79M), less than Armata Pharmaceuticals, Inc. (398.20M), less than Sangamo Therapeutics, Inc. (0), greater than Tonix Pharmaceuticals Holding Corp. (-86803860.00), less than Compugen Ltd. (181.24M), less than Nuvectis Pharma, Inc. (586.98M), less than Innate Pharma S.A. (128.31M), less than Insight Molecular Diagnostics Inc. (79.44M), less than Codexis, Inc. (165.87M), less than OmniAb, Inc. (747.72M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 381.79M | $403.55M | |
| 398.20M | $108.20M | |
| 0 | $30.66M | |
| -86803860.00 | $88.16M | |
| 181.24M | $188.50M | |
| 586.98M | $609.14M | |
| 128.31M | $158.94M | |
| 79.44M | $94.57M | |
| 165.87M | $120.46M | |
| 747.72M | $752.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vyome Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vyome Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vyome Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vyome Holdings, Inc. (HIND)?
What is the 3-year average Enterprise Value for Vyome Holdings, Inc. (HIND)?
What is the 5-year average Enterprise Value for Vyome Holdings, Inc. (HIND)?
How does the current Enterprise Value for Vyome Holdings, Inc. (HIND) compare to its historical average?